Home Cart 0 Sign in  
X

[ CAS No. 74137-36-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 74137-36-3
Chemical Structure| 74137-36-3
Chemical Structure| 74137-36-3
Structure of 74137-36-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 74137-36-3 ]

Related Doc. of [ 74137-36-3 ]

Alternatived Products of [ 74137-36-3 ]

Product Details of [ 74137-36-3 ]

CAS No. :74137-36-3 MDL No. :MFCD02258848
Formula : C7H6Br2O Boiling Point : -
Linear Structure Formula :- InChI Key :OQZAQBGJENJMHT-UHFFFAOYSA-N
M.W : 265.93 Pubchem ID :11021812
Synonyms :

Calculated chemistry of [ 74137-36-3 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 48.33
TPSA : 9.23 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.13 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.65
Log Po/w (XLOGP3) : 3.93
Log Po/w (WLOGP) : 3.22
Log Po/w (MLOGP) : 3.3
Log Po/w (SILICOS-IT) : 3.18
Consensus Log Po/w : 3.25

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.34
Solubility : 0.0121 mg/ml ; 0.0000454 mol/l
Class : Moderately soluble
Log S (Ali) : -3.82
Solubility : 0.04 mg/ml ; 0.00015 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.23
Solubility : 0.0156 mg/ml ; 0.0000587 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.6

Safety of [ 74137-36-3 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P301+P312-P302+P352-P304+P340-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 74137-36-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 74137-36-3 ]
  • Downstream synthetic route of [ 74137-36-3 ]

[ 74137-36-3 ] Synthesis Path-Upstream   1~26

  • 1
  • [ 88149-47-7 ]
  • [ 16618-67-0 ]
  • [ 74137-36-3 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1925, vol. 44, p. 194
[2] Recueil des Travaux Chimiques des Pays-Bas, 1925, vol. 44, p. 194
  • 2
  • [ 74137-36-3 ]
  • [ 74-88-4 ]
  • [ 29578-83-4 ]
Reference: [1] Patent: WO2008/43567, 2008, A1, . Location in patent: Page/Page column 32-33
  • 3
  • [ 626-39-1 ]
  • [ 124-41-4 ]
  • [ 621-23-8 ]
  • [ 20469-65-2 ]
  • [ 74137-36-3 ]
Reference: [1] Organic Preparations and Procedures International, 2003, vol. 35, # 2, p. 225 - 227
  • 4
  • [ 74137-36-3 ]
  • [ 626-41-5 ]
YieldReaction ConditionsOperation in experiment
97% With hydrogen bromide In water for 72 h; Heating / reflux 3,5-Dibromoanisole (15.57 g, 58.5 mmol) and tetrabutylammonium bromide (1.0 g, 3.1 mmol) were suspended in 48percent hydrobromic acid (100 mL) and refluxed for 3 days. After cooling to room temperature the reaction mixture was extracted with methylene chloride (3.x.60 mL). The combined organic layers were washed with water, dried over magnesium sulfate, and evaporated. The crude product was filtered over a pad of silica gel (ethyl acetate/heptane 10:1). After removal of the solvent, 14.23 g (97percent of 3,5-dibromophenol was obtained as pale brown needles.
97% With tetrabutylammomium bromide; hydrogen bromide In water for 72 h; Heating / reflux (b) 3,5-Dibromophenol. 3,5-Dibromoanisole (15.57 g, 58.5 mmol) and tetrabutylammonium bromide (1.0 g, 3.1 mmol) were suspended in 48percent hydrobromic acid (100 mL) and refluxed for 3 days. After cooling to room temperature the reaction mixture was extracted with methylene chloride (3.x.60 mL). The combined organic layers were washed with water, dried over magnesium sulfate, and evaporated. The crude product was filtered over a pad of silica gel (ethyl acetate/heptane 10:1). After removal of the solvent, 14.23 g (97percent of 3,5-dibromophenol was obtained as pale brown needles.
97% for 72 h; Heating / reflux [0295] (b) 3,5-Dihromophenol. 3,5-Dibromoanisole (15.57 g, 58.5 mmol) and tetrabutylammonium bromide (1.0 g, 3.1 mmol) were suspended in 48percent hydrobromic acid (100 mL) and refluxed for 3 days. After cooling to room temperature the reaction mixture was extracted with methylene chloride (3x60 mL). The combined organic layers were washed with water, dried over magnesium sulfate, and evaporated. The crude product was filtered over a pad of silica gel (ethyl acetate/heptane 10:1). After removal of the solvent, 14.23 g (97percent of 3,5-dibromophenol was obtained as pale brown needles.
90% With boron tribromide In dichloromethane at 0 - 20℃; for 51 h; Inert atmosphere; Darkness To a 250 mL two-necked flask was added 3,5-dibromoanisole (9) (5 g, 18.8 mmol, 1 eq.) Under argon, Anhydrous CH2Cl2 (80 mL) was added, BBr3 (3.5 mL, 37.6 mmol, 2 eq.) Was added dropwise at 0 ° C and maintained at 0 ° C for 3 hours and then allowed to warm to room temperature, The reaction was stopped after darkening for 2 days. The reaction was extracted with CH2Cl2 (50 mL x 3) Combine organic phase, Distilled water (50 mL x 3), Dried over anhydrous magnesium sulfate, The magnesium sulfate was removed by filtration, Steaming the solvent, The residue was purified by silica gel column chromatography (eluent: ether / petroleum ether = 1/9) 4.2 g of a white solid, Yield 90percent. Mp = 86-89 ° C.

Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 25, p. 8982 - 8983
[2] Patent: US2006/270686, 2006, A1, . Location in patent: Page/Page column 35
[3] Journal of Medicinal Chemistry, 2011, vol. 54, # 1, p. 179 - 200
[4] Patent: US2008/280891, 2008, A1, . Location in patent: Page/Page column 35
[5] Patent: WO2008/8059, 2008, A1, . Location in patent: Page/Page column 96
[6] Patent: CN103819479, 2017, B, . Location in patent: Paragraph 0034; 0049; 0050
[7] Chemical Communications, 2014, vol. 50, # 57, p. 7586 - 7589
[8] Patent: US2006/25462, 2006, A1, . Location in patent: Page/Page column 18
  • 5
  • [ 626-39-1 ]
  • [ 626-41-5 ]
  • [ 74137-36-3 ]
Reference: [1] Monatshefte fuer Chemie, 1886, vol. 7, p. 630
  • 6
  • [ 626-39-1 ]
  • [ 124-41-4 ]
  • [ 626-41-5 ]
  • [ 74137-36-3 ]
Reference: [1] Monatshefte fuer Chemie, 1886, vol. 7, p. 630
[2] Monatshefte fuer Chemie, 1886, vol. 7, p. 630
  • 7
  • [ 67-56-1 ]
  • [ 6311-60-0 ]
  • [ 74137-36-3 ]
YieldReaction ConditionsOperation in experiment
84% With potassium hydroxide In tetramethylurea at 20℃; for 24 h; 3,5-Dibromonitrobenzene (21.07 g, 75 mmol), freshly powdered potassium hydroxide (7.57 g, 135 mmol) and tetrabutylammonium bromide (2.42 g, 7.5 mmol) were suspended in tetramethyl urea (80 mL). To the resulting brown slurry was slowly added a solution of methanol (4.81 g, 6.09 mL, 150 mmol) in 20 mL of tetramethyl urea at room temperature over a period of 15 minutes. The mixture was stirred for 24 hours at room temperature then poured on ice (150 g) and was extracted with t-butyl methyl ether (3.x.250 mL). The combined organics were dried over magnesium sulfate and concentrated to give the crude product which was distilled (124° C., 10 Torr) to provide 16.74 g (84percent) of 3,5-dibromoanisole as a pale yellow solid.
84% at 20℃; for 24.25 h; (a) 3,5-Dibromoanisole. 3,5-Dibromonitrobenzene (21.07 g, 75 mmol), freshly powdered potassium hydroxide (7.57 g, 135 mmol) and tetrabutylammonium bromide (2.42 g, 7.5 mmol) were suspended in tetramethyl urea (80 mL). To the resulting brown slurry was slowly added a solution of methanol (4.81 g, 6.09 mL, 150 mmol) in 20 mL of tetramethyl urea at room temperature over a period of 15 minutes. The mixture was stirred for 24 hours at room temperature then poured on ice (150 g) and was extracted with t-butyl methyl ether (3.x.250 mL). The combined organics were dried over magnesium sulfate and concentrated to give the crude product which was distilled (124° C., 10 Torr) to provide 16.74 g (84percent) of 3,5-dibromoanisole as a pale yellow solid.
84% With potassium hydroxide; tetrabutylammomium bromide In tetramethylurea at 20℃; for 24.25 h; 0294] (a) 3,5-Dibromoanisole. 3,5-Dibromonitrobenzene (21.07 g, 75 mmol), freshly powdered potassium hydroxide (7.57g, 135 mmol) and tetrabutylammonium bromide (2.42 g, 7.5 mmol) were suspended in tetramethyl urea (80 mL). To the resulting brown slurry was slowly added a solution of methanol (4.81 g, 6.09 mL, 150 mmol) in 20 mL of tetramethyl urea at room temperature over a period of 15 minutes. The mixture was stirred for 24 hours at room temperature then poured on ice (150 g) and was extracted with t-butyl methyl ether (3x250 mL). The combined organics were dried over magnesium sulfate and concentrated to give the crude product which was distilled (1240C, 10 Torr) to provide 16.74 g (84percent) of 3,5- dibromoanisole as a pale yellow solid.
Reference: [1] Patent: US2006/270686, 2006, A1, . Location in patent: Page/Page column 35
[2] Journal of Medicinal Chemistry, 2011, vol. 54, # 1, p. 179 - 200
[3] Patent: US2008/280891, 2008, A1, . Location in patent: Page/Page column 34-35
[4] Patent: WO2008/8059, 2008, A1, . Location in patent: Page/Page column 96
  • 8
  • [ 626-41-5 ]
  • [ 74-88-4 ]
  • [ 74137-36-3 ]
YieldReaction ConditionsOperation in experiment
97% With potassium carbonate In acetone at 20℃; for 15 h; Heating; Reflux Step 1:
Preparation of 1,3-dibromo-5-methoxy-benzene
To a suspension of 3,5-dibromophenol (20 g, 79.39 mmol) and potassium carbonate (21.95 g, 158.78 mmol) in acetone (100 mL) was added iodomethane (24.79 g, 174.65 mmol) at room temperature.
The resulting light yellow color mixture was heated to reflux and stirred for 15 h at which time TLC analysis of the mixture indicated the absence of starting material.
Then, the reaction mixture was cooled to room temperature and diluted with water (200 mL) and ethyl acetate (200 mL).
The two layers were separated and the aqueous layer was extracted with ethyl acetate (100 mL).
The combined extracts were washed with brine solution (250 mL) and dried over anhydrous magnesium sulfate.
Filtration of the drying agent and the concentration of the solution under reduced pressure gave the crude residue which was purified by using an ISCO 330 g column chromatography, eluding with 0-3percent ethyl acetate in hexanes to obtain 1,3-dibromo-5-methoxy-benzene (20.47 g, 97percent) as a white solid: EI(+)-HRMS m/e calcd for C7H6Br2O (M)+ 263.8780, found 263.8785.
Reference: [1] Patent: US2009/227603, 2009, A1, . Location in patent: Page/Page column 55-56
[2] Chemistry - An Asian Journal, 2012, vol. 7, # 10, p. 2230 - 2234,5
[3] Chemistry - An Asian Journal, 2012, vol. 7, # 10, p. 2230 - 2234
[4] Chemistry - A European Journal, 2008, vol. 14, # 13, p. 3883 - 3888
[5] Organometallics, 2015, vol. 34, # 1, p. 133 - 145
  • 9
  • [ 1435-51-4 ]
  • [ 124-41-4 ]
  • [ 74137-36-3 ]
YieldReaction ConditionsOperation in experiment
95% at 20℃; To a 500 mL round bottom flask was added 3,5-dibromofluorobenzene (8) (20.0 g, 0.08 mol, 1 eq.) And anhydrous DMF (350 mL). To a round bottom flask was slowly added sodium methoxide (5.2 g , 0.09 mol, 1.2 eq.), Stir at room temperature overnight, Then add 5percent HCl to neutralize, Stop the reaction. CH2Cl2 extraction (50 mL x 3), The organic phase was washed with distilled water (50 mL x 3) The organic phase was dried over anhydrous magnesium sulfate, The magnesium sulfate was removed by filtration, The solvent was removed by flash evaporation to give a pale yellow solid, Silica gel column chromatography (eluent: petroleum ether), A white solid was obtained 30 g, Yield 95percent.
Reference: [1] Patent: CN103819479, 2017, B, . Location in patent: Paragraph 0034; 0046; 0047
[2] Patent: WO2004/31156, 2004, A1, . Location in patent: Page 28
[3] Patent: US2007/78128, 2007, A1, . Location in patent: Page/Page column 22
[4] Patent: US2007/88015, 2007, A1, . Location in patent: Page/Page column 24
[5] Patent: US2008/45511, 2008, A1, . Location in patent: Page/Page column 22
[6] Patent: US2008/293664, 2008, A1, . Location in patent: Page/Page column 15-16
[7] Patent: US2008/249151, 2008, A1, . Location in patent: Page/Page column 20
[8] Patent: US2009/170856, 2009, A1, . Location in patent: Page/Page column 24
[9] Patent: WO2004/24147, 2004, A1, . Location in patent: Page/Page column 18
[10] Patent: WO2004/31178, 2004, A1, . Location in patent: Page 25
[11] Patent: WO2004/29051, 2004, A1, . Location in patent: Page 38
[12] Patent: US2005/54707, 2005, A1, . Location in patent: Page/Page column 11
[13] Patent: US2006/25462, 2006, A1, . Location in patent: Page/Page column 21-22
[14] Patent: US2006/223874, 2006, A1, . Location in patent: Page/Page column 6; 11
  • 10
  • [ 95970-05-1 ]
  • [ 74137-36-3 ]
YieldReaction ConditionsOperation in experiment
96% With sulfuric acid; hypophosphorous acid; sodium nitrite In toluene at 0℃; for 4.5 h; To a solution of 2,6-dibromo-4-methoxyphenylamine (3 g, 10.67 mmol, 1 eq) in 10 ml of toluene cooled at 0° C. are added 6.6 ml of concentrated sulfuric acid and 17.5 ml of H3PO2 50percent (15 eq).
To the reaction mixture, sodium nitrite (1.47 mg, 21.35 mmol, 2 eq) is added, and all is stirred at 0° C. for 4.5 h.
After neutralization with a sodium hydroxide solution, extraction with diethyl ether is performed.
The organic phase is dried over magnesium sulfate, filtered and evaporated to dryness on a rotary evaporator.
Purification of the raw product was not necessary (yield 96percent, 2.7 g).
C7H6Br2O; MW 264/266/268; 1H-NMR (CDCl3): δ 7.23-7.22 (m, 1H), 6.97 (s, 1H), 6.96 (s, 1H), 3.75 (s, 3H); 13C-NMR: δ 160.8, 126.4, 123.1, 116.5, 55.7; IR: 2925, 1599, 1569, 1464 1/cm
Reference: [1] Patent: US2010/204234, 2010, A1, . Location in patent: Page/Page column 13
  • 11
  • [ 1435-51-4 ]
  • [ 74137-36-3 ]
Reference: [1] Patent: WO2004/29042, 2004, A1, . Location in patent: Page 24
[2] Patent: US2003/100554, 2003, A1,
  • 12
  • [ 626-39-1 ]
  • [ 74137-36-3 ]
Reference: [1] Organic Letters, 2010, vol. 12, # 20, p. 4560 - 4563
  • 13
  • [ 626-39-1 ]
  • [ 124-41-4 ]
  • [ 74137-36-3 ]
Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 25, p. 8982 - 8983
[2] European Journal of Organic Chemistry, 2009, # 15, p. 2562 - 2575
[3] Chemical Communications, 2014, vol. 50, # 57, p. 7586 - 7589
[4] Journal of Organic Chemistry USSR (English Translation), 1988, vol. 24, # 3, p. 516 - 522[5] Zhurnal Organicheskoi Khimii, 1988, vol. 24, # 3, p. 577 - 583
[6] Patent: US2010/261701, 2010, A1, . Location in patent: Page/Page column 240
  • 14
  • [ 626-39-1 ]
  • [ 124-41-4 ]
  • [ 621-23-8 ]
  • [ 20469-65-2 ]
  • [ 74137-36-3 ]
Reference: [1] Organic Preparations and Procedures International, 2003, vol. 35, # 2, p. 225 - 227
  • 15
  • [ 626-41-5 ]
  • [ 77-78-1 ]
  • [ 74137-36-3 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1908, vol. 27, p. 36
[2] Monatshefte fuer Chemie, 1925, vol. 46, p. 95
[3] Journal of Organic Chemistry, 1966, vol. 31, p. 3666 - 3671
  • 16
  • [ 827-94-1 ]
  • [ 74137-36-3 ]
Reference: [1] Patent: US2008/280891, 2008, A1,
[2] Patent: WO2008/8059, 2008, A1,
  • 17
  • [ 626-39-1 ]
  • [ 626-41-5 ]
  • [ 74137-36-3 ]
Reference: [1] Monatshefte fuer Chemie, 1886, vol. 7, p. 630
  • 18
  • [ 608-71-9 ]
  • [ 74-88-4 ]
  • [ 74137-36-3 ]
Reference: [1] Tetrahedron Letters, 1995, vol. 36, # 40, p. 7327 - 7328
  • 19
  • [ 90-04-0 ]
  • [ 74137-36-3 ]
Reference: [1] Monatshefte fuer Chemie, 1915, vol. 36, p. 132
  • 20
  • [ 88149-47-7 ]
  • [ 16618-67-0 ]
  • [ 74137-36-3 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1925, vol. 44, p. 194
[2] Recueil des Travaux Chimiques des Pays-Bas, 1925, vol. 44, p. 194
  • 21
  • [ 626-40-4 ]
  • [ 74137-36-3 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1908, vol. 27, p. 36
  • 22
  • [ 88149-47-7 ]
  • [ 74137-36-3 ]
Reference: [1] Monatshefte fuer Chemie, 1915, vol. 36, p. 132
[2] Journal of Organic Chemistry USSR (English Translation), 1984, vol. 20, p. 2357 - 2366[3] Zhurnal Organicheskoi Khimii, 1984, vol. 20, # 12, p. 2588 - 2599
[4] Monatshefte fuer Chemie, 1915, vol. 36, p. 132
  • 23
  • [ 626-39-1 ]
  • [ 124-41-4 ]
  • [ 626-41-5 ]
  • [ 74137-36-3 ]
Reference: [1] Monatshefte fuer Chemie, 1886, vol. 7, p. 630
[2] Monatshefte fuer Chemie, 1886, vol. 7, p. 630
  • 24
  • [ 74137-36-3 ]
  • [ 570391-20-7 ]
Reference: [1] Patent: US2008/280891, 2008, A1,
[2] Patent: WO2008/8059, 2008, A1,
  • 25
  • [ 74137-36-3 ]
  • [ 68-12-2 ]
  • [ 262450-65-7 ]
YieldReaction ConditionsOperation in experiment
98% With n-butyllithium In diethyl ether at -78℃; for 0.75 h; n-BuLi (2.6 mL of a 1.6 M solution, 1.1 equiv) was added slowly to a solution of the 180a (1.0 g, 3.8 mmol) in Et2O (20 mL) cooled to -78° C. under an N2 atmosphere.
The solution was stirred for 45 min, and DMF was added via syringe.
The solution was warmed slowly to RT, added to saturated ammonium chloride, and extracted with ether.
The organic phase was washed with brine and dried (MgSO4), filtered and evaporated to afford 0.80 g (98percent) of 180b.
98%
Stage #1: With n-butyllithium In diethyl ether at -78℃; for 0.75 h;
Stage #2: at -78 - 20℃;
Preparation of 3-bromo-5-cyano-phenol (CASRN 770718-92-8)
step 1-n-BuLi (2.6 mL of a 1.6 M solution, 1.1 equiv) was added slowly to a solution of the 1,3-dibromo-5-methoxy-benzene (1.0 g, 3.8 mmol, CAS Reg. No. 74137-36-3) in Et2O (20 mL) cooled to -78° C. under an N2 atmosphere.
The solution was stirred for 45 min, and DMF was added via syringe.
The solution was warmed slowly to RT, added to saturated ammonium chloride, and extracted with ether.
The organic phase was washed with brine and dried (MgSO4), filtered and evaporated to afford 0.80 g (98percent) of 1-bromo-3-formyl-benzaldehyde.
98%
Stage #1: With n-butyllithium In diethyl ether at -78℃; for 0.75 h;
Stage #2: at 20℃;
step 1-n-BuLi (2.6 mL of a 1.6 M solution, 1.1 equiv) was added slowly to a solution of the 1,3-dibromo-5-methoxy-benzene (1.0 g, 3.8 mmol, CAS Reg. No. 74137-36-3) in Et2O (20 mL) cooled to -78° C. under an N2 atmosphere.
The solution was stirred for 45 min, and DMF was added via syringe.
The solution was warmed slowly to RT, added to saturated ammonium chloride, and extracted with ether.
The organic phase was washed with brine and dried (MgSO4), filtered and evaporated to afford 0.80 g (98percent) of 1-bromo-3-formyl-benzaldehyde.
98%
Stage #1: With n-butyllithium In diethyl ether at -78℃; for 0.75 h;
Stage #2: at 20℃;
Stage #3: With water; ammonium chloride In diethyl ether
[3-(3-Bromo-5-cyano-phenoxy)-4-chloro-2-fluoro-phenyl]-acetic Acid Ethyl Ester (R-20c) step 1-n-BuLi (2.6 mL of a 1.6 M solution, 1.1 equiv) was added slowly to a solution of the R-21a (1.0 g, 3.8 mmol, CAS Reg. No. 74137-36-3) in Et2O (20 mL) cooled to -78° C. under an N2 atmosphere. The solution was stirred for 45 min, and DMF was added via syringe. The solution was warmed slowly to RT, added to saturated ammonium chloride, and extracted with ether. The organic phase was washed with brine and dried (MgSO4), filtered and evaporated to afford 0.80 g (98percent) of R-21b.
98%
Stage #1: With n-butyllithium In diethyl ether; hexane at -78℃; for 0.75 h; Inert atmosphere
Stage #2: at 20℃;
Example 2
2-(3-(4-Isopropylpiperazin-1-yl)-5-methoxyphenyl)-5,7-dimethoxyquinazolin-4(3H)-one
A solution of 1,3-dibromo-5-methoxybenzene (5.00 g, 18.8 mmol) in anhydrous diethyl ether (100 mL) was cooled to -78° C. Then a solution of n-butyllithium in hexanes (2.5 M, 8.3 mL, 20.68 mmol) was added drop-wise at -78° C. under nitrogen.
After the addition was complete, the reaction was stirred at -78° C. for 45 min.
After that time, anhydrous DMF (7.3 mL), 94.0 mmol) was added, the cooling bath was removed and the reaction mixture was allowed to warm to rt.
The reaction was diluted with saturated aqueous NH4Cl solution (100 mL) and diethyl ether (100 mL).
The organic phase was separated, washed with water, dried over anhydrous Na2SO4 and concentrated under reduced pressure to give 3-bromo-5-methoxybenzaldehyde (3.95 g, 98percent) as yellow oil: 1H NMR (400 MHz, CDCl3) δ9.90 (s, 1H), 7.57-7.60 (m, 1H), 7.31-7.33 (m, 2H), 3.86 (s, 3H).
96%
Stage #1: With n-butyllithium In diethyl ether at -78℃;
Stage #2: at -78 - 20℃;
Step 1
A solution of 1,3-dibromo-5-methoxybenzene (15 g, 56.40 mmol) in anhydrous Et2O (200 ML) under nitrogen was cooled to -78° C. n-BuLi (38.80 ML of a 1.6 M solution in Et2O, 62.00 mmol) was added dropwise, and the solution was aged at -78° C. for 45 m.To the resulting heterogeneous mixture was added anhydrous DMF (4.78 ML, 62.00 mmol), and the solution was slowly warmed to RT.
The mixture was poured into H2O (200 ML), and the aqueous phase was extracted with Et2O (3*125 ML).The combined organic fractions were washed with brine (100 ML) and dried over anhydrous MgSO4.Evaporation of the solvent provided 11.70 g (96percent) of 3-bromo-5-methoxybenzaldehyde (115)115).

Reference: [1] Patent: US2005/239881, 2005, A1, . Location in patent: Page/Page column 47
[2] Patent: US2008/293664, 2008, A1, . Location in patent: Page/Page column 16
[3] Patent: US2008/249151, 2008, A1, . Location in patent: Page/Page column 21
[4] Patent: US2009/170856, 2009, A1, . Location in patent: Page/Page column 23
[5] Journal of Medicinal Chemistry, 2008, vol. 51, # 21, p. 6839 - 6852
[6] Patent: US2014/142102, 2014, A1, . Location in patent: Paragraph 0512
[7] Patent: US2004/198736, 2004, A1, . Location in patent: Page/Page column 80
[8] Patent: US2008/293664, 2008, A1, . Location in patent: Page/Page column 16
[9] Patent: US2008/249151, 2008, A1, . Location in patent: Page/Page column 20-21
[10] Patent: US2009/170856, 2009, A1, . Location in patent: Page/Page column 24
[11] Patent: US2006/25462, 2006, A1, . Location in patent: Page/Page column 21-22
[12] Patent: US2006/223874, 2006, A1, . Location in patent: Page/Page column 6; 11
  • 26
  • [ 60-29-7 ]
  • [ 74137-36-3 ]
  • [ 262450-65-7 ]
Reference: [1] Patent: US2007/88015, 2007, A1, . Location in patent: Page/Page column 24
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 74137-36-3 ]

Aryls

Chemical Structure| 2398-37-0

[ 2398-37-0 ]

1-Bromo-3-methoxybenzene

Similarity: 0.97

Chemical Structure| 17332-12-6

[ 17332-12-6 ]

3-Bromo-4-methoxyphenol

Similarity: 0.95

Chemical Structure| 20469-65-2

[ 20469-65-2 ]

1-Bromo-3,5-dimethoxybenzene

Similarity: 0.94

Chemical Structure| 855400-66-7

[ 855400-66-7 ]

3-Bromo-5-methoxyphenol

Similarity: 0.94

Chemical Structure| 62415-74-1

[ 62415-74-1 ]

1,2-Dibromo-4-methoxybenzene

Similarity: 0.92

Bromides

Chemical Structure| 2398-37-0

[ 2398-37-0 ]

1-Bromo-3-methoxybenzene

Similarity: 0.97

Chemical Structure| 17332-12-6

[ 17332-12-6 ]

3-Bromo-4-methoxyphenol

Similarity: 0.95

Chemical Structure| 20469-65-2

[ 20469-65-2 ]

1-Bromo-3,5-dimethoxybenzene

Similarity: 0.94

Chemical Structure| 855400-66-7

[ 855400-66-7 ]

3-Bromo-5-methoxyphenol

Similarity: 0.94

Chemical Structure| 62415-74-1

[ 62415-74-1 ]

1,2-Dibromo-4-methoxybenzene

Similarity: 0.92

Ethers

Chemical Structure| 2398-37-0

[ 2398-37-0 ]

1-Bromo-3-methoxybenzene

Similarity: 0.97

Chemical Structure| 17332-12-6

[ 17332-12-6 ]

3-Bromo-4-methoxyphenol

Similarity: 0.95

Chemical Structure| 20469-65-2

[ 20469-65-2 ]

1-Bromo-3,5-dimethoxybenzene

Similarity: 0.94

Chemical Structure| 855400-66-7

[ 855400-66-7 ]

3-Bromo-5-methoxyphenol

Similarity: 0.94

Chemical Structure| 62415-74-1

[ 62415-74-1 ]

1,2-Dibromo-4-methoxybenzene

Similarity: 0.92